This company seems to have been delisted
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Advaxis
ADXS
S$0.03840
Share price
0.00%
Change (1 day)
-95.15%
Change (1 year)
Categories
Advaxis (ADXS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : S$52.47 Million
According to Advaxis's latest financial reports the company's total liabilities are S$52.47 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Advaxis - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | S$54.14 M | 355.43% |
| 2022-12-31 | S$11.88 M | 26.18% |
| 2021-12-31 | S$9.42 M | -4.15% |
| 2020-12-31 | S$9.82 M | -87.64% |
| 2019-12-31 | S$79.5 M | 18.81% |
| 2018-12-31 | S$66.91 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Inovio Pharmaceuticals INO | S$46.1 M | -12.13% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | S$33.79 M | -35.60% | 🇺🇸 USA |
 Heska Corporation
HSKA | S$0.22 B | 326.98% | 🇺🇸 USA |